NIXANIDE 500 TAB is a clinically proven oral formulation containing Nitazoxanide 500 mg, an innovative broad-spectrum anti-infective agent indicated for the treatment of acute infectious diarrhea and other gastrointestinal infections. Nitazoxanide is known for its unique mechanism, wherein it interferes with the pyruvate:ferredoxin oxidoreductase enzyme-dependent electron transfer reaction that is essential for anaerobic energy metabolism in a variety of protozoa and anaerobic bacteria. This disruption leads to inhibition of pathogen growth and ultimately results in the resolution of symptoms associated with infections such as cryptosporidiosis, giardiasis, and bacterial gastroenteritis.
Developed for patients suffering from acute, often debilitating, diarrhea, NIXANIDE 500 TAB provides rapid relief by reducing pathogen load and improving gut function. Its broad-spectrum activity makes it particularly effective in settings where mixed infections are common. Moreover, by reducing the duration and severity of symptoms, this medication helps in preventing dehydration and nutritional deficiencies that often accompany prolonged diarrheal illness.
Manufactured by Bluepill Express in WHO-GMP certified, ISO-compliant facilities, NIXANIDE 500 TAB adheres to rigorous quality control standards. Each batch is subjected to stringent testing for potency, dissolution, stability, and microbial safety to ensure that every tablet meets international regulatory requirements. The product is available in export-ready packaging, such as blister or alu-alu packs, with customizable labeling options to meet the branding needs and regulatory specifications of diverse global markets.
NIXANIDE 500 TAB is typically administered as a single daily dose or as prescribed by a healthcare professional, depending on the severity of the infection and patient-specific factors. It is recommended to be taken with water, ideally with food to enhance drug absorption and minimize gastrointestinal discomfort. Appropriate dosage adjustments and treatment duration are determined by the clinician based on the patient’s condition and response to therapy.
This formulation is an essential addition to the antimicrobial therapeutic portfolio, particularly in regions facing high incidences of gastrointestinal infections. It has been widely incorporated into public health programs and is trusted by clinicians for its effective action against a range of enteric pathogens. In addition to its clinical benefits, NIXANIDE 500 TAB is favored for its ease of administration, predictable pharmacokinetics, and low incidence of systemic side effects.
Bluepill Express not only ensures that NIXANIDE 500 TAB meets top-tier pharmaceutical standards, but also provides comprehensive export documentation including Certificates of Analysis (COA), Material Safety Data Sheets (MSDS), Stability Data, and regulatory dossiers in CTD format. These documents facilitate the registration and approval process in targeted international markets, such as Africa, Latin America, Southeast Asia, and the Middle East.
Description provided by bluepill express.
FIEO Registered
Export Ready
